Fundraising Fox
Tagworks Pharmaceuticals
Nijmegen, NL · Founded 2011 · 44 employees on LinkedIn · 10 known investors
Find your way into Tagworks Pharmaceuticals
Sign up to see every warm intro you have to Tagworks Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tagworks Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target. Its lead program targets TAG72, a non-internalizing marker expressed in difficult-to-treat solid tumors, aiming to expand ADC target scope and therapeutic window.
Investors · 10
How we know: Bif's portfolio page · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · a partner's Signal profile · biopharmadive.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: biopharmadive.com · Not right? Tell us
How we know: Novartis Venture Fund's portfolio page · a partner's Signal profile · funding news · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Ysios Capital's portfolio page · funding news · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$65M disclosed across 1 round · 2023
- $65MSeries AJun 2023 · 4 sources
Gilde Healthcare (lead), Ysios Capital (lead), Lightstone Ventures, Meneldor, New Enterprise Associates, Novartis Venture Fund, Novartis' venture arm, Oost NL
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 3
Companies working in the same space as Tagworks Pharmaceuticals.
In the news
Frequently asked questions
- What does Tagworks Pharmaceuticals do?
- Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target. Its lead program targets TAG72, a non-internalizing marker expressed in difficult-to-treat solid tumors, aiming to expand ADC target scope and therapeutic window.
- Who are Tagworks Pharmaceuticals's investors?
- Tagworks Pharmaceuticals's investors include Bif, Lightstone Ventures, New Enterprise Associates (NEA), Novartis Venture Fund, Ysios Capital, Clarus Ventures, Gilde Healthcare, Oost NL.
- How much funding has Tagworks Pharmaceuticals raised?
- Tagworks Pharmaceuticals has disclosed $65M raised across 1 round.
- Where is Tagworks Pharmaceuticals headquartered?
- Tagworks Pharmaceuticals is headquartered in Nijmegen, NL.